Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 11, 2009, Pages 2125-2128

  Marques, Francine Z ^a   Markus, M Andrea ^a   Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aging; SIRT1; Sirtuin activators; trans Resveratrol

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; PLACEBO; RESVERATROL; SIRTUIN; SRT 2104; SRT 501; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; DEGENERATIVE DISEASE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DYSLIPIDEMIA; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LIFE EXTENSION; METABOLIC DISORDER; METASTASIS INHIBITION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; RHEUMATOID ARTHRITIS; SHORT SURVEY; WEIGHT REDUCTION;

BIOLOGICAL PRODUCTS; HEALTH; HUMANS; STILBENES;

EID: 70349265983     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.06.003     Document Type: Short Survey

References (20)

1. Bastianetto S., Dumont Y., Han Y., and Quirion R. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site?. CNS Neurosci Ther 15 (2009) 76-83
2. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
3. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 (2006) 493-506
4. Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16 (2007) 1246-1252
5. Brooks C.L., and Gu W. How does SIRT1 affect metabolism, senescence and cancer?. Nat Rev Cancer 9 (2009) 123-128
6. Danz E.D., Skramsted J., Henry N., Bennett J.A., and Keller R.S. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46 (2009) 1589-1597
7. Della-Morte D., Dave K.R., Defazio R.A., Bao Y.C., Raval A.P., and Perez-Pinzon M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159 (2009) 993-1002
8. Feige J.N., Lagouge M., Canto C., Strehle A., Houten S.M., Milne J.C., et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8 (2008) 347-358
9. Jin F., Wu Q., Lu Y.F., Gong Q.H., and Shi J.S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600 (2008) 78-82
10. Jung-Hynes B., Nihal M., Zhong W., and Ahmad N. Role of sirtuin histone deacetylase SIRT1 in prostate cancer A target for prostate cancer management via its inhibition?. J Biol Chem 284 (2009) 3823-3832
11. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
12. Markus M.A., and Morris B.J. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 3 (2008) 331-339
13. Nicholson S.K., Tucker G.A., and Brameld J.M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 67 (2008) 42-47
14. Park J.S., Kim K.M., Kim M.H., Chang H.J., Baek M.K., Kim S.M., et al. Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res 29 (2009) 355-362
15. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8 (2008) 157-168
16. Rayalam S., Yang J.Y., Ambati S., Della-Fera M.A., and Baile C.A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22 (2008) 1367-1371
17. Rivera L., Moron R., Zarzuelo A., and Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77 (2009) 1053-1063
18. Shakibaei M., Harikumar K.B., and Aggarwal B.B. Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53 (2009) 115-128
19. Smith J.J., Kenney R.D., Gagne D.J., Frushour B.P., Ladd W., Galonek H.L., et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst Biol 3 (2009) 31
20. Yang Y.T., Weng C.J., Ho C.T., and Yen G.C. Resveratrol analog-3,5,4′-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol Nutr Food Res 53 (2009) 407-416